Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barni

Showing results (231-240 of 369) with videos related to

Pageof 37
Sort By:
The International Journal of Biological Markers|October 1, 1992
Effects of interleukin-2 immunotherapy on soluble lymphocyte markers in cancer patientsP Lissoni, F Rovelli, E Tisi, et al.
Tumori|June 30, 1994
Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactinS Barni, P Lissoni, F Brivio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian studyG Mustacchi, M Mansutti, C Sacco, et al.
Tumori|August 31, 1986
Prolactin response to thyrotropin-releasing hormone in early and advanced human breast cancerS Barni, P Lissoni, G Tancini, et al.
Oncology|November 1, 1995
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretionP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1993
Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2P Lissoni, A Ardizzoia, E Tisi, et al.
The International Journal of Biological Markers|April 1, 1991
Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancerS Barni, P Lissoni, D Mandelli, et al.
Tumori|August 31, 1994
Vinorelbine as single agent in pretreated patients with advanced breast cancerS Barni, A Ardizzoia, G Bernardo, et al.
Tumori|December 31, 1993
A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinomaP Lissoni, S Barni, A Ardizzoia, et al.
Anticancer Research|May 1, 1990
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancerP Lissoni, S Barni, C Archili, et al.
Pageof 37

Showing results (231-240 of 369) with videos related to

Sort By:
Pageof 37
The International Journal of Biological Markers|October 1, 1992
Effects of interleukin-2 immunotherapy on soluble lymphocyte markers in cancer patientsP Lissoni, F Rovelli, E Tisi, et al.
Tumori|June 30, 1994
Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactinS Barni, P Lissoni, F Brivio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian studyG Mustacchi, M Mansutti, C Sacco, et al.
Tumori|August 31, 1986
Prolactin response to thyrotropin-releasing hormone in early and advanced human breast cancerS Barni, P Lissoni, G Tancini, et al.
Oncology|November 1, 1995
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretionP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1993
Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2P Lissoni, A Ardizzoia, E Tisi, et al.
The International Journal of Biological Markers|April 1, 1991
Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancerS Barni, P Lissoni, D Mandelli, et al.
Tumori|August 31, 1994
Vinorelbine as single agent in pretreated patients with advanced breast cancerS Barni, A Ardizzoia, G Bernardo, et al.
Tumori|December 31, 1993
A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinomaP Lissoni, S Barni, A Ardizzoia, et al.
Anticancer Research|May 1, 1990
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancerP Lissoni, S Barni, C Archili, et al.
Pageof 37